VRCA CIK: 1660334

Verrica Pharmaceuticals Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY24
millions USD
FY21:
12.0
FY22:
8.31
FY23:
4.62
FY24:
4.97
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−30.9
FY22:
−22.0
FY23:
−66.3
FY24:
−68.5
FY25:
−12.2
(positive)
Change from FY21 to FY22
millions USD
FY21:
−30.3
FY22:
−20.2
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY22
millions USD
FY21:
−35.1
FY22:
−24.5
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−35.1
FY22:
−24.5
FY23:
−67.0
FY24:
−76.6
FY25:
−17.9

All amounts in millions USD Data sources:SEC EDGARTwelve Data